Astex Pharmaceuticals, Inc. ASTX +5.19% , a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that it will release its 2012 second quarter financial results on Monday, July 30, 2012. James S.J. Manuso, PhD, chairman and chief executive officer, and the Astex Pharmaceuticals management team will provide details of the Company's financial results and any revised outlook for the future.
A press release will be issued following the close of the market on July 30th. The Company will host a webcast conference call to discuss the results at 4:30 p.m. ET. A live webcast of the call may be accessed through the Events Calendar in the Investors section of the Company's website at www.astx.com . A webcast replay of the conference call will be available shortly following the event. Alternatively, a replay of the conference call may be accessed by dialing (855) 859-2056 (domestic) and (404) 537-3406 (international); the replay passcode number is 13949485. The webcast replay will be available for 30 days, and the telephone replay will be available for 7 days.
No comments:
Post a Comment